P

Assignee

CIPLA LTD

IN122 patents

Top patents by PatentIndex Score

USD590495SApr 14, 2009

Multidose inhaler

CIPLA LTD48 citations96
US9901585B2Feb 27, 2018

Combination of azelastine and fluticasone for nasal administration

CIPLA LTD12 citations93
US7638627B2Dec 29, 2009

Process of preparing imatinib and imatinib prepared thereby

CIPLA LTD22 citations93
USD590938SApr 21, 2009

Multidose inhaler

CIPLA LTD43 citations92
US7404400B2Jul 29, 2008

Spacer device for inhaler

CIPLA LTD34 citations92
US9227990B2Jan 5, 2016

Antiviral phosphonate analogues and process for preparation thereof

CIPLA LTD14 citations84
USD646780SOct 11, 2011

Inhaler device

CIPLA LTD10 citations84
US8006695B2Aug 30, 2011

Inhaler

CIPLA LTD12 citations84
USD631956SFeb 1, 2011

Aerosal delivery device

CIPLA LTD11 citations84
USD605497SDec 8, 2009

Cantilever

CIPLA LTD10 citations84
USD591856SMay 5, 2009

Mouth piece

CIPLA LTD14 citations84
USD590057SApr 7, 2009

Inhaler

CIPLA LTD8 citations84
US7395821B2Jul 8, 2008

Multi-dose inhaler

CIPLA LTD13 citations84
US6995286B2Feb 7, 2006

Process for preparing isomers of salbutamol

CIPLA LTD11 citations83
US10328153B2Jun 25, 2019

Rifaximin complexes

CIPLA LTD3 citations82
US9993560B2Jun 12, 2018

Rifaximin complexes

CIPLA LTD3 citations82
US10301282B2May 28, 2019

Polymorphic form X of nilotinib dihydrochloride hydrate

CIPLA LTD6 citations81
US9913853B2Mar 13, 2018

Stabilized liquid fosaprepitant formulations

CIPLA LTD7 citations81
US10940274B2Mar 9, 2021

Nasal spray assembly

CIPLA LTD9 citations78
US10098890B2Oct 16, 2018

Stable carfilzomib formulations

CIPLA LTD7 citations78
USD563546SMar 4, 2008

Device for inhalation

CIPLA LTD7 citations74
US7285669B2Oct 23, 2007

Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole

CIPLA LTD8 citations74
US10912734B2Feb 9, 2021

Depot formulation

CIPLA LTD2 citations72
US7470789B2Dec 30, 2008

Fexofenadine polymorphs and processes of preparing the same

CIPLA LTD6 citations72
US7112577B2Sep 26, 2006

Pharmaceutically acceptable alendronate salts in amorphous form

CIPLA LTD6 citations72
US11077124B2Aug 3, 2021

Pharmaceutical compositions

CIPLA LTD2 citations71
US9993561B2Jun 12, 2018

Rifaximin complexes

CIPLA LTD3 citations71
US10307432B2Jun 4, 2019

Stabilized liquid fosaprepitant formulations

CIPLA LTD2 citations70
US10966982B2Apr 6, 2021

Stable pharmaceutical formulations of pemetrexed

CIPLA LTD2 citations63
US9446054B2Sep 20, 2016

Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids

CIPLA LTD2 citations63
US9259428B2Feb 16, 2016

Combination of azelastine and fluticasone for nasal administration

CIPLA LTD2 citations63
US8937057B2Jan 20, 2015

Combination of azelastine and mometasone for nasal administration

CIPLA LTD2 citations63
US8933060B2Jan 13, 2015

Combination of azelastine and ciclesonide for nasal administration

CIPLA LTD2 citations63
US7989636B2Aug 2, 2011

Process for the preparation of pure anastrozole

CIPLA LTD2 citations63
US7538249B2May 26, 2009

Tolterodine, compositions and uses thereof, and preparation of the same

CIPLA LTD4 citations63
US7439367B2Oct 21, 2008

Pharmaceutical process and compounds prepared thereby

CIPLA LTD2 citations63
US7351840B2Apr 1, 2008

Perindopril

CIPLA LTD3 citations63
US11596597B2Mar 7, 2023

Depot formulation

CIPLA LTD0 citations62
US11478483B2Oct 25, 2022

Method of treating hypertension

CIPLA LTD0 citations62
US11224591B2Jan 18, 2022

Pharmaceutical compositions comprising rifaximin

CIPLA LTD0 citations62
US11207319B2Dec 28, 2021

Method for the treatment of bladder cancer

CIPLA LTD0 citations62
US11129836B2Sep 28, 2021

PAR-4 agonists for the treatment of cancer

CIPLA LTD0 citations62
US10709715B2Jul 14, 2020

Method of treating hypertension

CIPLA LTD1 citations62
US10391080B2Aug 27, 2019

Ketorolac for the treatment of cancer

CIPLA LTD1 citations62
USD604831SNov 24, 2009

Base

CIPLA LTD2 citations62
USD579958SNov 4, 2008

Drive gear for a dose counter

CIPLA LTD3 citations62
US12109270B2Oct 8, 2024

Rifaximin complexes

CIPLA LTD0 citations61
US12109200B2Oct 8, 2024

Rifaximin

CIPLA LTD0 citations61
USRE43984EFeb 5, 2013

Process for preparing isomers of salbutamol

CIPLA LTD1 citations61
US12472190B2Nov 18, 2025

Pharmaceutical compositions

CIPLA LTD0 citations60

Showing the top 50 of 122 patents by PatentIndex Score.